Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 50090-7334

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 50090-7334). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)

Bupropion Hydrochloride Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of bupropion hydrochloride showing a chlorophenyl ring attached to a carbonyl and amine group with methyl substituents, along with the hydrochloride salt component.*
FDA Label Image

Label Image (Lbl500907334)

Label Image (Lbl500907334)
Bupropion Hydrochloride Extended Release (XL) 300 mg film-coated tablets packaging label from A-S Medication Solutions. The label indicates oral tablet dosage form, one tablet taken once daily, nicotine and bupropion release specified. The package contains 30 tablets with storage instructions at 77 degrees Fahrenheit. NDC 50090-7334-0 and additional packaging information visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.